Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 31 March 2011, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £11.90 per Ordinary share and $38.34 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2011 to 31 March 2011:
Non Executive Director |
Ordinary Shares |
American Depository Shares (ADSs) |
Sir Christopher Gent |
2836.13 |
|
Prof. Sir Roy Anderson |
866.60 |
|
Dr Stephanie Burns |
|
540.82 |
Mr Lawrence Culp |
|
1081.63 |
Sir Crispin Davis |
3256.30 |
|
Sir Deryck Maughan |
|
772.59 |
Mr James Murdoch |
2836.13 |
|
Dr Daniel Podolsky |
|
1043.00 |
Mr Tom de Swaan |
1129.20 |
|
Sir Robert Wilson |
866.60 |
|
The Company and the Non-Executive Directors were informed of these allocations on 1 April 2011.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
4 April 2011